3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

The invention provides compounds of Formula I as inhibitors of cancer stem cells as well as cancer stem cell pathway kinase and other related kinases, pharmaceutical compositions and uses thereof in the treatment of cancer or a related disorder in a mammal, wherein i.a. R2 is an optionally substitut...

Full description

Saved in:
Bibliographic Details
Main Authors WEI LIU, JI-FENG LIU, AMANDA GIBEAU, HARRY ROGOFF, TOSHIO KANAI, KATSUNORI TSUBOL, TOMOHIRO KODAMA, SHINGO TOJO, KATSUMI KUBOTA, YOSUKE TAKANASHI, CHIANG J. LI
Format Patent
LanguageEnglish
Spanish
Published 31.05.2016
Subjects
Online AccessGet full text

Cover

Loading…